Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma

Siddiqi T, Thomas SH, Chen R

Pharmacogenomics and Personalized Medicine 2014, 7:79-85

Published Date: 20 February 2014